Table 1

Drug application and related inhibition

DrugApplication1-aInhibitionChange1-b
%
GABA young86.2  ± 12 nA/sec29.9  ± 1.4
GABA old96.0  ± 10 nA/sec30.9  ± 1.1
ISO old40.7  ± 5.4 nA36.3  ± 4.94.6  ± 5.1
FORSK young (100 μM)5.4  ± 1.1 psi42.3  ± 5.212.2  ± 5.7
FORSK old (100 μM)9.9  ± 1.8 psi1-c 29.6  ± 3.1−6.2  ± 3.6
7β-FORSK young (100 μM)4.9  ± 1.8 psi55.2  ± 6.126.5  ± 7.5
7β-FORSK old (1 mM)5.5  ± 1.1 psi33.0  ± 3.72.08  ± 3.3
100 μM Sp-cAMPS young4.9  ± 1.6 psi53.3  ± 3.126.0  ± 2.8
10 μM Sp-cAMPS old1.4  ± 0.4 psi32.5  ± 2.73.2  ± 1.8
100 μM Sp-CAMPS old5.24  ± 1.0 psi24.8  ± 2.9−3.9  ± 2.7
1 mM Sp-cAMPS old6.6  ± 1.5 psi50.3  ± 3.615.2  ± 3.8
  • Values are mean ± S.E.M.

  • 1-a Drug application from the electrode in nanoamps or psi. When applications times are <120 secs, then time influences the amount of drug being ejected. If time is not noted, this indicates application times of >120 secs, and at these times, a steady state level is reached and the pressure or current adequately represents the “dose.”

  • 1-b Percent change indicates the difference in percent inhibition to GABA before drug application and during drug application. For example, if the GABA-induced inhibition before FORSK was 20% and the inhibition during FORSK was 70%, then the percent change would be 50%.

  • 1-c P < .05 vs. young FORSK application.